Match Document Document Title
DE10004815B4 Human intestinal sodium phosphate cotransporter  
Npt2B polypeptide having an amino acid sequence which is identical to the sequence SEQ ID NO. 01 and sodium phosphate co-transporter having activity.
DE102008029356A1 A method for purifying nucleic acids, in particular of fixed tissue  
The invention relates to a method for purification of nucleic acids, a kit for performing the inventive method, as well as a novel use of magnetic particles for purifying a biological sample. The...
DE102008025328A1 Detecting HIV in a blood sample comprises providing and optionally concentrating the sample, extracting viral nucleic acids, adding the extract to PCR master mix and performing amplification and detecting the amplified viral nucleic acids  
Method (A) for detecting HIV in a sample derived from blood comprises: (a) providing the sample derived from blood; (b) optionally concentrating the sample derived from blood; (c) extracting viral...
DE102008024309A1 New tetrahydro-pyran compounds useful to prepare 2-desoxy-2-(F-18)fluoroglucosyl-1-azide, which is useful for F-18-glycosylation of bioactive alkynyl or ethinyl derivatized molecule to form conjugated tetrahydro-pyran biomolecule  
Tetrahydro-pyran compounds (I) are new. Tetrahydro-pyran compounds of formula (I) are new. 3 of R 1-R 4= a leaving group comprising OAc and the other is OSO 2R', and R'= methyl, trifluoromethyl or...
DE19831609B4 A process for producing amino acids of the aspartate and / or glutamate family and used in the process means  
A process for microbial production of amino acids of the aspartate and / or glutamate family in which the pyruvate-carboxylase activity of a corresponding amino acid-producing microorganism is...
DE102008023301A1 New nucleophilic cytosine derivatives and their applications  
The invention relates to the novel and not previously used in the synthesis of cytidines silylated cytosine analogs 4c and 4d as well as their use for reactions with 3,5-protected sugars of...
DE102008022017A1 Preparing 1,4-benzothiepin-1,1-dioxide derivative, comprises e.g. reacting mercaptomethyl-hexanol compound with difluorobenzoyl-azinic acid compound and converting into e.g. benzo(b)thiepin-4-ol compound followed by isolating and purifying  
Preparation of 1,4-benzothiepin-1,1-dioxide derivative (I), comprises e.g. reacting (S)-2-ethyl-2-mercaptomethyl-hexan-1-ol (V) with [3-(2,5-difluorobenzoyl)phenyl]azinic acid (VIII), followed by...
DE19937019B4 A method for producing 4-aryl-2-butanols from Taxus wallichiana  
A method for producing two 4-aryl-2-butanols with the general formula 1 wherein R = H or glucose is, from the leaves of Taxus wallichiana, comprising the steps of: (A) degreasing air-dried,...
DE10154290B4 A method for detecting periodontal disease and caries-associated bacteria  
A method for detecting periodontal disease or tooth decay associated bacteria by amplification and hybridization, comprising the steps of A) amplifying nucleic acid to fragments from the genome of...
DE102008017590A1 Glucopyranosidderivate  
New compounds of formula I whereinX has the meaning given in claim 1, useful as antidiabetic agents.
DE102005031755B4 Salmonella spp. binding peptides, nucleic acids encoding the Verwenduen and methods and kits for enrichment, immobilization and detection of Salmonella spp.  
Salmonella spp. binding peptide selected from the sequences SEQ ID NO. 1 to NO. 3, SEQ ID NO. 5 to NO. 8, SEQ ID NO. 10, SEQ ID NO. 12, SEQ ID NO. 14 to NO. 16, SEQ ID NO. 18, SEQ ID NO. 20 to NO....
DE102008012295A1 Mixture for the production of rapidly disintegrating tablets  
Isomalt-containing mixture, comprising a) 60-97 wt .-% agglomerated isomalt, b) 1-25 wt .-% cross-linked polyvinylpyrrolidone, c) 0.1-15 wt .-% lubricant, d) 1-15 wt. -% water-insoluble,...
DE102008012015A1 Improved isomalt-containing compressed formulations and methods for their preparation  
The present invention relates to improved isomalt-containing compacts and methods for their preparation.
DE102008010693A1 New matrix materials, to processes for their preparation and their use in methods for isolating biomolecules  
The present invention berifft functionalized matrix materials or matrices which have the structures of the general formula I Processes for their preparation and their use for purification and...
DE102008010584A1 Detecting anaerobic microorganisms capable of degrading aromatic compounds comprises using nucleotide sequences coding for a conserved amino acid sequence of 6-oxocyclohexene-1-carbonyl coenzyme A hydrolase  
Detecting anaerobic microorganisms that are capable of degrading aromatic compounds comprises contacting an environmental sample with nucleotide sequences coding for a conserved amino acid...
DE10084502B4 A method for purification of nucleic acid with silicon carbide  
A method for isolating a Nucleotidpolymers from a sample, comprising the steps of: Adding silicon carbide to the sample and mixing, to bind the Nucleotidpolymer to the silicon carbide; Separating...
DE102008008270A1 Novel cyclic oxo-silanes based on sugar derivatives and process for their preparation  
Are given for the preparation thereof novel cyclic oxo-silanes based on sugar derivatives and methods. As part of the invention is, inter alia, succeeded in introducing silicon atoms at the...
DE102008008193A1 Roller- or plain bearing forgery-proof marking of a valuable document, comprises a bearing body with a surface, and a marking that enables a clear identification of the bearing body and comprises a synthetic nucleic acid  
The roller- or plain bearing (6) comprises a bearing body with a surface (1), and a marking that enables a clear identification of the bearing body and comprises a synthetic nucleic acid (4)...
DE102008006416A1 Clindamycin or its salt, or a clindamycin-containing composition useful for the intracervical or endocervical treatment or prevention of bacterial vaginosis caused by anaerobic and gram positive aerobic germs  
Clindamycin or its salt, or a clindamycin-containing composition useful for the intracervical or endocervical treatment or prevention of bacterial vaginosis caused by anaerobic and gram positive...
DE102008000101A1 A process for obtaining D-galactose from vegetable raw material by acid hydrolysis  
Disclosed is a method for the recovery of D-galactose, comprising the steps of:- Providing an aqueous solution or suspension of Galactoarabinan, wherein the aqueous solution or phase has a pH of...
DE102008054480A1 Direct sequencing by ATP release  
There is provided a method for sequencing a nucleic acid. In certain embodiments, the method comprises contacting a nucleic acid duplex comprising a template and a nucleic acid annealed to the...
DE102007062962A1 New surface protein mutant of hepatitis B virus HBV surface antigen (HBsAg)  
The invention relates to sequences of a new mutant or variant of the hepatitis B surface antigen (HBsAg) and methods, these genomic and protein variant and antibodies directed against them from...
DE102007052119A1 New coumermycin A1-derivative, useful as biologically active substance and as antibiotics or cytostatics, and for preventing diseases caused by bacteria or tumor  
Coumermycin A1-derivative (I), is new. Coumermycin A1-derivative of formula (I), is new. R1, R2 : CH 3, halo or H, preferably H, F, Cl, Br or I, where both R1, R2 are not simultaneously CH 3. An...
DE10128250B4 Glykolipidderivate new, processes for their preparation and compositions comprising them  
connection of the general formula (I) or the pharmaceutically acceptable salts from that, wherein W is a chain with 9 to 17 carbon atoms, optionally containing one double bond or hydroxy group may...
DE102008050273A1 Apparatus and method for synthesizing a biopolymer and method for recovering a reagent for synthesizing a biopolymer  
A Apparatus for synthesizing a biopolymer has a reaction chamber (100), an outlet (410b) connected to the reaction chamber (100) is connected, a plurality of recovery tanks (461A, 461C, 461g,...
DE202008016372U1 Vitamin containing composition  
vitamin containing composition, particularly suitable for nutritional accounted supplement food in inner ear disorders, said composition comprising as an effective Constituents substances...
DE19520398B4 Magnetic pigment  
reagent composition for isolating nucleic acids from a sample comprising (A) magnetic particles having a Glass surface, (B) a chaotropic salt solution, (C) optionally a washing solution and (D)...
DE102008012336A1 Separation of charged absolute electrostatic repulsion / hydrophilic interaction  
In one aspect includes a method of conducting an electrostatic repulsion / hydrophilic interaction chromatography to a protein, a peptide or an amino acid, the Providing a column with an...
DE102007041476A1 Aptamers that bind to a party to the hemostasis target molecule  
The Invention relates to an aptamer that binds to an haemostasis participating target molecule binds with the aptamer an aptamer is that binds to activated protein C, wherein the aptamer with a...
DE102007044765A1 A process for the liquid phase synthesis of a polymer  
The Invention relates to a process for the liquid phase synthesis of a n monomers formed polymer.
DE202007018725U1 Oligonucleotide probes and containing these diagnostic kits for the determination of linezolid resistance  
Oligonucleotide probe hybridizing specifically with ribosomal RNA of microorganisms, the specific ribosomal to an under hybridization conditions RNA of the microorganism, the induced by a...
DE102005029811B4 Oligonucleotide arrays, methods for their use, and their use  
oligonucleotide arrays comprising at least two by at least one spacer linked hybridizable oligonucleotide as primer sequences, characterized in that the spacer is selected from functionalized...
DE102005011003B9 Method and means for the differential diagnosis of thyroid tumors  
process for the differential diagnosis of thyroid tumors to differentiate of benign tumors to malicious Tumors wherein: 1) RNA is isolated from a tissue sample of the thyroid gland, 2.) in the...
DE102007038037A1 Eukaryotic promoters for gene expression  
The Invention provides promoters prepared from yeast Arxula adeninivorans which are nitrate inducible genes of nitrate reductase (AYNR1) Nitrite (AYNI1) or the nitrate transporter (AYNT1) descended.
DE102004063099B4 A process for preparing Thiophenglycosidderivaten  
process for the preparation of compounds of general formula (I): which mean YH, (C1-C10) Alkyl; R1 (C1-C8th) -alkyl, Where one, several, or all hydrogen (s) may be replaced by fluorine; (C5-C10)...
DE19805822B4 11-acetyl-12,13-dioxabicyclo [8.2.1] tridecenon derivatives, processes for their preparation and pharmaceutical compositions containing them  
(2R,3S,4S,5R,6R,10R,11R)-2,4,6,8,10-Pentamethyl-11-acetyl-12 ,13-dioxabicyclo[8.2.1]tridec-8-en-1-on-Verbindungen of the general formula I wherein R1 hydrogen or methyl and R2 hydrogen or...
DE102008028357A1 New Hybrid System for Brassica napus  
The present invention relates to a conditional kerngenisch inherited Male sterility system in Brassica napus. Embodiments of the present invention provide the (Male sterile) female line precursor...
DE102007035730A1 Determining linezolid-resistance in microorganism comprises contacting microorganism with oligonucleotide-probe that can bind to microorganism ribosomal RNA showing point mutation caused by linezolid-resistance and detecting microorganism  
Determination of linezolid-resistance in microorganisms present in a sample, comprises contacting the sample with at least an oligonucleotide-probe, which can bind under hybridization conditions...
DE102007035250A1 A method for separating non-proteinaceous biomolecules, in particular nucleic acids from protein-containing samples  
The This invention relates to a process for isolating non-proteinaceous biomolecules, in particular nucleic acids, wherein on a solid phase, a protein degradation is carried out.
DE102007032799A1 New sugar-containing polypyridine metal complexes e.g. useful as fluorescence markers in biological systems or for treating abnormal cells  
Sugar-containing polypyridine metal complexes (I) are new. Sugar-containing polypyridine metal complexes of formula (I) are new. (L1 n)(L2 m)(L3 o)(L4 p)(L5 q)M (I) L1-L5 : ligands, at least one...
DE60224401T2 HEPATITIS C VIRUS POLYMERASE INHIBITORS WITH HETEROBICYLISCHER STRUCTURE  
An isomer, enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein: A is O, S, N R 1 , or C R 1 , wherein R 1 is defined herein; ----- represents either a single...
DE10319917B4 Process for the selective carbohydrate oxidation using a supported gold catalysts  
process for the selective oxidation of carbohydrates, carbohydrate blend or composition containing the same, wherein an aqueous solution of Carbohydrate, the mixture or composition in the presence...
DE102007028030A1 Biosurfactants and their preparation  
The Invention relates to a process for Biotensidherstellung wherein biotensiderzeugende microorganisms in a growing medium be moved. It is provided that the growing medium used in excess and a...
DE60224400T2 HEPATITIS C VIRUS POLYMERASE INHIBITORS WITH HETEROBICYLISCHER STRUCTURE  
An isomer, enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein: A is O, S, N R 1 , or C R 1 , wherein R 1 is defined herein; ----- represents either a single...
DE19730408B4 Composition for topical application  
composition for external use with at least one particulate material selected is selected from the group (A) of the ellagic acid-based compound of the general formula (I): where R1. R2, R3 and R4...
DE102007053947A1 A process for the synthesis of sucrose-6-acetic acid ester  
The This invention discloses a method for the synthesis of sucrose-6-acetic acid esters, comprising the steps of: adding sucrose in a polar, aprotic solvent and stirring the solvent, to solve...
DE102006035392A1 Prognostic markers for predicting the five-year progression-free survival of patients with colon cancer based on expression profiles of biological samples  
The Invention relates to the use of gene expression profiles for Prediction of the five-year progression-or relapse-free survival of patients undergoing colorectal a was removed carcinoma in UICC...
DE102007016367A1 Polymorph of Clarithromycin (Form V)  
The Invention relates to a polymorphic form of clarithromycin (form V), their preparation and use.
DE102007015775A1 A method for detecting Paratuberkolose  
The This invention relates to a method for specifically and sensitive detection of Mycobacterium avium ssp. paratuberculosis (MAP). In fecal, tissue and organ samples using a real-time PCR methods
DE102006050091A1 Process for the selective localization of active ingredients to and in mitochondria and corresponding active ingredients  
The This invention relates to novel processes for the selective localization of active ingredients both at and in mitochondria within living cells and agents that through without further aids...